Comparison of TP53 mutation analysis findings for tar pitch dermatopathy and ionizing radiation-related skin cancer

被引:0
|
作者
Ishino, Keiko [1 ]
Yamada, Hidetaka [1 ]
Kahyo, Tomoaki [1 ]
Hino, Ryosuke [2 ]
Nakamura, Motonobu [2 ]
Shimajiri, Shohei [3 ]
Hisaoka, Masanori [4 ]
Kasami, Masako [5 ]
Tokura, Yoshiki [6 ]
Sugimura, Haruhiko [1 ]
机构
[1] Hamamatsu Univ, Sch Med, Dept Tumor Pathol, 1-20-1 Handayama,Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan
[2] Univ Occupat & Environm Hlth, Dept Dermatol, Kitakyushu, Fukuoka, Japan
[3] Univ Occupat & Environm Hlth, Dept Surg Pathol, Kitakyushu, Fukuoka, Japan
[4] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Oncol, Kitakyushu, Fukuoka, Japan
[5] Iwata City Hosp, Div Diagnost Pathol, Iwata, Shizuoka, Japan
[6] Chutoen Gen Med Ctr, Allerg Dis Res Ctr, Kakegawa, Shizuoka, Japan
关键词
TP53; mutation spectrum; Tar-pitch dermatopathy; skin cancer; radiation; environmental carcinogenesis; P53; MUTATION;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Tar has been well known as a carcinogen ever since Yamagiwa artificially induced carcinogenesis for the first time by painting a rabbit ear with tar 100 years ago. While humans can be exposed to tar under numerous circumstances, few molecular pathological analyses of skin lesions caused by "tar pitch dermatopathy" have been performed because tar pitch dermatopathy itself is currently rare. Methods: A mutation analysis of TP53 was conducted using long-term stored formalin-fixed, paraffin-embedded tissue specimens of tar pitch dermatopathy in 4 subjects; a similar analysis of radiation-induced skin cancer in 2 subjects was also performed for comparison. Multiple sites were analyzed. Results: Among the specimens from the 4 subjects with tar pitch dermatopathy, the mutations c.625A>T and c.715A>G were each found in 1 of the lesion specimens, whereas the wild type for TP53 was seen in all the non-tumorous skin samples from these cases. The additional mutation c.503A>C was also detected in a different portion of the specimen from the case in which c.715A>G had been detected. In contrast, in 1of the 2 cases with radiation-induced skin cancer (3 squamous cell carcinoma lesions), the novel mutations c.224delC and c.470delT were found at dipyrimidine sites of TP53 . Thus, the mutation spectrum found in tar pitch dermatopathy did not include G>T transversions arising from benzo(a)pyrene, as expected, but instead included the mutation c.625A>T, which is prevalent among tobacco-related cancers according to the IARC database. Conclusions: Skin malignancy developing under peculiar conditions provides an opportunity to investigate the human reality of environmental carcinogenesis. Although a small piece of data this information will be helpful for understanding human skin carcinogenesis in terms of occupational exposure to environmental substances and informative in precision medicine especially in precision prevention.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Comparison of TP53 mutation analysis findings for tar pitch dermatopathy and ionizing radiation-related skin cancer
    Ishino, Keiko
    Yamada, Hidetaka
    Kahyo, Tomoaki
    Hino, Ryosuke
    Nakamura, Motonobu
    Shimajiri, Shohei
    Hisaoka, Masanori
    Kasami, Masako
    Tokura, Yoshiki
    Sugimura, Haruhiko
    JOURNAL OF LABORATORY AND PRECISION MEDICINE, 2022, 7
  • [2] Somatic hematopoietic TP53 mosaicism in women with breast cancer exposed to ionizing radiation
    Melnov, Sergey
    Murphy, Patricia
    Foley, Thomas
    Nadyrov, Eldar
    Kipen, Vyacheslav
    Leushev, Boris
    Modugno, Francesmary
    BREAST JOURNAL, 2018, 24 (05): : 852 - 854
  • [3] TP53 Mutation Estimation Based on MRI Radiomics Analysis for Breast Cancer
    Sun, Kun
    Zhu, Hong
    Chai, Weimin
    Yan, Fuhua
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, 57 (04) : 1095 - 1103
  • [4] Editorial for "TP53 Mutation Estimation Based on Radiomics Analysis for Breast Cancer"
    Thakur, Sunitha B.
    Chakraborthy, Jayasree
    Pinker, Katja
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, 57 (04) : 1104 - 1105
  • [5] Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment
    Leroy, Bernard
    Girard, Luc
    Hollestelle, Antoinette
    Minna, John D.
    Gazdar, Adi F.
    Soussi, Thierry
    HUMAN MUTATION, 2014, 35 (06) : 756 - 765
  • [6] Loss of Heterozygosity and TP53 Gene Mutation Analysis in Multifocal Lung Cancer
    Cheng, L.
    Wang, X.
    Wang, M.
    Zhang, S.
    MacLennan, G.
    Lopez-Beltran, A.
    Montironi, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 662 - 663
  • [7] TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods
    Kantorova, Barbara
    Malcikova, Jitka
    Smardova, Jana
    Pavlova, Sarka
    Trbusek, Martin
    Tom, Nikola
    Plevova, Karla
    Tichy, Boris
    Truong, Sim
    Diviskova, Eva
    Kotaskova, Jana
    Oltova, Alexandra
    Patten, Nancy
    Brychtova, Yvona
    Doubek, Michael
    Mayer, Jiri
    Pospisilova, Sarka
    TUMOR BIOLOGY, 2015, 36 (05) : 3371 - 3380
  • [8] Accumulation, activation and interindividual variation of the epidermal TP53 protein in response to ionizing radiation in organ cultured human skin
    Pond, CD
    Leachman, SA
    Warters, RL
    RADIATION RESEARCH, 2004, 161 (06) : 739 - 745
  • [9] Apparently "BRCA-Related" Breast and Ovarian Cancer Patient With Germline TP53 Mutation
    Janavicius, Ramunas
    Andrekute, Kristina
    Mickys, Ugnius
    Rudaitis, Vilius
    Brasiuniene, Birute
    Griskevicius, Laimonas
    BREAST JOURNAL, 2011, 17 (04): : 409 - 415
  • [10] TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort
    J. J. Bakhuizen
    F. B. Hogervorst
    M. E. Velthuizen
    M. W. Ruijs
    K. van Engelen
    T. A. van Os
    J. J. Gille
    M. Collée
    A. M. van den Ouweland
    C. J. van Asperen
    C. M. Kets
    A. R. Mensenkamp
    E. M. Leter
    M. J. Blok
    M. M. de Jong
    M. G. Ausems
    Familial Cancer, 2019, 18 : 273 - 280